Dysregulation of AQP5 has been associated with various diseases, including Sjögren’s syndrome (SS) [6], bronchitis [7] and cystic fibrosis [8], stressing the clinical significance for understanding the molecular mechanisms governing AQP5 trafficking and function. This evidence concerns the gene AQP5 and cystic fibrosis.